title: Management of skin cancer after organ transplantation.
abstract: Advances in transplant surgery and more effective immunosuppressive regimen have led to increased survival rates among transplant recipients. However, intense immunosuppression has led to increased rates of both internal and cutaneous malignancies, with skin cancer occurring as the most common cancer after transplantation. While many transplant recipients will develop mild and manageable cutaneous malignancies, some will develop potentially life-threatening disease. Dermatologists are an integral part in the care of organ transplant recipients. Therefore, it is important for dermatologists to be familiar with the available epidemiological data and management of skin cancers in this patient population. In this paper, we review the risk factors, prevention, recognition and effective intervention of skin cancers in organ transplant recipients.
authors.affiliation: Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA.
authors.forename: W
authors.initials: W
authors.lastname: Lumbang
authors.forename: T
authors.initials: T
authors.lastname: Stasko
mesh_terms: D002294:Carcinoma, Squamous Cell / Q000209:etiology / Q000628:therapy; D006801:Humans; D007165:Immunosuppression Therapy / Q000009:adverse effects*; D016377:Organ Transplantation; D011230:Precancerous Conditions; D012307:Risk Factors; D012878:Skin Neoplasms / Q000453:epidemiology / Q000209:etiology* / Q000628:therapy